| Variable | Site of tumor | P-value | ||||
| Right colon (n = 80) | Left colon (n = 80) | |||||
| N | % | N | % | |||
| Age (years), Mean ± SD |
| 49.06 ± 14.38 | 44.74 ± 14.83 | 0.037 | ||
| <45 years | 27 | 33.75 | 40 | 50.00 | ||
| ≥45 years | 53 | 66.25 | 40 | 50.00 | ||
| Gender | Male | 43 | 53.75 | 37 | 46.25 | 0.343 |
| Female | 37 | 46.25 | 43 | 53.75 | ||
| Risk factors | None | 41 | 51.25 | 35 | 43.75 | 0.568 |
| Family history | 14 | 17.50 | 20 | 25.00 | ||
| Smoking | 10 | 12.50 | 7 | 8.75 | ||
| Obesity | 7 | 8.75 | 6 | 7.50 | ||
| Pre-cancerous lesions | 8 | 10.00 | 12 | 15.00 | ||
| Presenting symptoms | Abdominal pain | 41 | 51.25 | 21 | 26.25 | 0.001 |
| Bleeding manifestations | 7 | 8.75 | 23 | 28.75 | ||
| Altered bowel habits | 16 | 20.00 | 15 | 18.75 | ||
| Intestinal obstruction | 16 | 20.00 | 18 | 22.50 | ||
| Intestinal perforation | 0 | 0.00 | 1 | 1.25 | ||
| Symptoms of metastases | 0 | 0.00 | 2 | 2.50 | ||
| Sites of metastases | None | 31 | 38.75 | 25 | 31.25 | 0.320 |
| Liver | 22 | 27.50 | 30 | 37.50 | 0.177 | |
| Lung | 3 | 3.75 | 9 | 11.25 | 0.072 | |
| Bone | 8 | 10.00 | 5 | 6.25 | 0.385 | |
| Brain | 3 | 3.75 | 1 | 1.25 | 0.620 | |
| Ascites | 12 | 15.00 | 11 | 13.75 | 0.822 | |
| Abdominal LNs | 10 | 12.50 | 13 | 16.25 | 0.499 | |
| Peritoneal deposits | 29 | 36.25 | 31 | 38.75 | 0.744 | |
| Number of metastatic sites | 0 | 31 | 38.75 | 25 | 31.25 | 0.556 |
| 1 | 20 | 25.00 | 21 | 26.25 | ||
| 2 | 22 | 27.50 | 22 | 27.50 | ||
| 3 | 6 | 7.50 | 11 | 13.75 | ||
| 4 | 0 | 0.00 | 1 | 1.25 | ||
| 5 | 1 | 1.25 | 0 | 0.00 | ||
| Pathology | Adenocarcinoma | 52 | 65.00 | 61 | 76.25 | 0.135 |
| Mucoid adenocarcinoma | 23 | 28.75 | 14 | 17.50 | ||
| Signet ring carcinoma | 3 | 3.75 | 5 | 6.25 | ||
| Neuroendocrine carcinoma | 2 | 2.50 | 0 | 0.00 | ||